Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels (Q34661015)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels
scientific article

    Statements

    Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit